Steven J Bensinger

Title: The Innovative Contributions of Steven J Bensinger

Introduction

Steven J Bensinger is a notable inventor based in Sherman Oaks, California. He has made significant contributions to the field of therapeutic methods aimed at modulating inflammation. His work focuses on the modulation of intracellular coenzyme A levels, which has implications for treating various inflammatory diseases.

Latest Patents

Bensinger holds a patent for "Methods and agents for modulating inflammation." This patent describes methods and agents that can modulate intracellular coenzyme A levels for therapeutic purposes. Increasing intracellular coenzyme A can lead to alternate macrophage activation, which helps suppress or resolve immune responses, benefiting the treatment of inflammatory diseases. Conversely, decreasing intracellular coenzyme A levels can be advantageous in treating conditions such as NASH/NAFLD and various fibrotic diseases. This modulation also plays a role in reversing the immune-suppressing activity of tumor-associated immune cells, such as macrophages, which is crucial for cancer treatment. He has 1 patent to his name.

Career Highlights

Bensinger is affiliated with the University of California, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on therapeutic strategies for inflammatory and fibrotic diseases.

Collaborations

Some of his notable coworkers include Ajit Srinivas Divakaruni and Anne N Murphy. Their collaborative efforts contribute to the ongoing research and development in the field of inflammation modulation.

Conclusion

Steven J Bensinger's innovative work in modulating inflammation through intracellular coenzyme A levels showcases his commitment to advancing therapeutic methods. His contributions are vital for the treatment of various diseases, highlighting the importance of research in this area.